Bupropion Impurity 31 CAS CATO-C4X-120331

Description

Compared with other compounds in its class, the molecular weight of 287.77 g/mol gives Bupropion Impurity 31 distinctive chromatographic separation conditions and mass-spectrometry parameter settings.

CATO supplies Bupropion Impurity 31 (CAS CATO-C4X-120331), a pharmacopoeial impurity reference standard (molecular formula C12H14ClNO3S, MW 287.77 g/mol) used for the identification and quantification of trace impurities in APIs.

Bupropion Impurity 31 (C12H14ClNO3S) contains a nitrogen-containing heterocyclic scaffold, an amide group, a sulfone group, a hydroxyl group, an ether linkage, chlorine substitution. It is notably hygroscopic, halogen substitution raises its density and boiling point, its high carbon-to-hydrogen ratio confers good lipid solubility, the carboxyl group imparts weak acidity; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.

Physical & Chemical Properties

Why CATO?

• ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
• 130,000+ catalog items in stock, COA supplied with every batch
• Worldwide shipping with full export documentation (HS code guidance available)
• Technical support: +86 18665070610 / Nicole.chen@cato-chem.com